HU Charles 胡正忠

Dr. Charles Hu

  • Founder & CEO, Ryoden Medical Holdings Ltd
  • Co-founder & Chief Medical Affairs Officer, Incando Therapeutics Ltd
  • Founding Partner, Cere Ventures Ltd
  • Johns Hopkins University, PhD in Tissue Engineering and Regenerative Medicine

A translational biomedical engineer with a passion in business development and investments, Charles’s vision is in bringing about a vibrant healthcare innovation and investment ecosystem in the HK Greater Bay Area.  

Charles’s scientific expertise interfaces across tissue engineering, regenerative medicine, interventional radiology, and materials science.  He is experienced in research commercialization and pharmaceutical medical affairs.  He co-founded Incando Therapeutics, a medical therapeutics company specializing in diseases of the brain and in bringing innovative technologies to the clinical stage.

On the business front, Charles heads Ryoden Medical where he oversees healthcare venture investments for his family office. He also advises angels, and is keen on working with universities and government-related bodies to inspire passion in and support for biomedical developments.

Charles is a member of the Hong Kong Professionals and Senior Executives Association, an Industrial Advisor of Biomedical Engineering and visiting Assistant Professor of Biomedical Sciences at City University of Hong Kong, board member of two biotechnology startups and other businesses.  He received the Guangdong-HK-Macao Greater Bay Area Outstanding Young Entrepreneur and Best Technology Innovation Award in 2023.